New York, New York--(Newsfile Corp. - August 31, 2026) - Kaplan Fox & Kilsheimer LLP is investigatin

New York, New York--(Newsfile Corp. - August 28, 2026) - Kaplan Fox & Kilsheimer LLP is investigatin

New York, New York--(Newsfile Corp. - August 26, 2026) - Kaplan Fox & Kilsheimer LLP is investigatin

New York, New York--(Newsfile Corp. - August 24, 2026) - Kaplan Fox & Kilsheimer LLP is investigatin

New York, New York--(Newsfile Corp. - August 21, 2026) - Kaplan Fox & Kilsheimer LLP is investigatin

RADNOR, Pa., Aug. 21, 2026 (GLOBE NEWSWIRE) -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a

New York, New York--(Newsfile Corp. - August 19, 2026) - Kaplan Fox & Kilsheimer LLP is investigatin

RADNOR, Pa., Aug. 18, 2026 /PRNewswire/ -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nati

New York, New York--(Newsfile Corp. - August 17, 2026) - Kaplan Fox & Kilsheimer LLP is investigatin

RADNOR, Pa., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a

New York, New York--(Newsfile Corp. - August 14, 2026) - Kaplan Fox & Kilsheimer LLP is investigatin

RADNOR, Pa., Aug. 13, 2026 /PRNewswire/ -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nati

FDA alerts providers as Medline corrects convenience kits with recalled BD applicators due to steril

RADNOR, Pa., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a

New York, New York--(Newsfile Corp. - August 12, 2026) - Kaplan Fox & Kilsheimer LLP is investigatin

JP Morgan analyst Lisa Gill maintains Medline (NASDAQ:MDLN) with a Overweight and lowers the pric

Wells Fargo analyst Stephen Baxter maintains Medline (NASDAQ:MDLN) with a Equal-Weight and lowers

TD Cowen analyst Charles Rhyee maintains Medline (NASDAQ:MDLN) with a Buy and lowers the price ta

New York, New York--(Newsfile Corp. - August 10, 2026) - Kaplan Fox & Kilsheimer LLP is investigatin

Cetera Investment Advisers grew its stake in Medline (NASDAQ: MDLN) by 128.4% in the first quarter,

RADNOR, Pa., Aug. 7, 2026 /PRNewswire/ -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a natio

New York, New York--(Newsfile Corp. - August 7, 2026) - Kaplan Fox & Kilsheimer LLP is investigating

RADNOR, Pa.--(BUSINESS WIRE)-- #classaction--Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a na

RBC Capital analyst Ryan Halsted maintains Medline (NASDAQ:MDLN) with a Outperform and lowers the

Truist Securities analyst Jailendra Singh maintains Medline (NASDAQ:MDLN) with a Buy and lowers t

Evercore ISI Group analyst Elizabeth Anderson maintains Medline (NASDAQ:MDLN) with a Outperform a

Allspring Growth Fund outperformed the Russell 3000 Growth Index during the quarter. Sandisk Corp. i

Medline Inc. (MDLN) Q2 2026 Earnings Call Transcript

Gold posts its biggest one-day gain since February and the Dow sets a record as Iran deal hopes cool

Medline (NASDAQ:MDLN) reported quarterly earnings of $0.50 per share which beat the analyst consensu

Medline (NASDAQ:MDLN) today announced that it signed a new Prime Vendor agreement with Allina Health

Jim Cramer says Medline is "probably" the best IPO of 2026 and expects AST SpaceMobile to be

Medline (MDLN) faces near-term headwinds after a major CA warehouse fire. William Blair analysts bre

Baird analyst Eric Coldwell maintains Medline (NASDAQ:MDLN) with a Outperform and lowers the pric

https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/m

Barclays analyst Glen Santangelo maintains Medline (NASDAQ:MDLN) with a Overweight and lowers the

Medline (NASDAQ:MDLN) announced that Medline Canada has signed its first Prime Vendor agreement in t

Medline (NASDAQ:MDLN) today announced that it signed a new Prime Vendor agreement with Rural Medical

Medline Inc. (NASDAQ:MDLN) ("Medline") announced today that certain selling stockholders aff

BNP Paribas analyst Navann Ty maintains Medline (NASDAQ:MDLN) with a Neutral and lowers the price

Tigress Financial analyst Ivan Feinseth maintains Medline (NASDAQ:MDLN) with a Buy and raises the

Citigroup analyst Patrick Donnelly maintains Medline (NASDAQ:MDLN) with a Buy and lowers the pric

Bernstein analyst Lee Hambright maintains Medline (NASDAQ:MDLN) with a Outperform and lowers the

https://www.fda.gov/medical-devices/letters-health-care-providers/disruptions-availability-neurosurg

Medline (NASDAQ:MDLN) reported quarterly earnings of $0.33 per share which beat the analyst consensu

https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=219163

Medline (NASDAQ:MDLN) announced a strategic agreement to implement next-generation warehouse automat

U.S. stock futures lower, with Dow futures down 150 points. Fastenal shares dip 4% after meeting ear